Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs EVL vs Combination for Variceal Bleed Prevention
NCT03069339Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Mar 2017
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carvedilol in esophageal varices (3 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Reduction in the incidence of first variceal bleed at 1 year. Status: unknown.
02
Drugs
carvedilol
03
Conditions
esophageal varices
Beyond the preview
Go deeper on NCT03069339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03069339.